FIELD: medicine.
SUBSTANCE: method involves administering corticosteroid preparations and cytostatics. Intravenous drop infusions of 1.5% Reamberin solution are additionally introduced beginning from the seventh treatment day in the amount of 400 ml once a day during 10 days.
EFFECT: reduced risk of adverse side effects and complications.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF ACANTHOLYTIC PEMPHIGUS | 2003 |
|
RU2233163C1 |
| METHOD OF TREATING PEMPHIGUS VULGARIS | 2012 |
|
RU2530625C2 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
| APPLICATION OF SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES TO TYPE 3 DESMOGLEIN FROM BLOOD SERUM OF PATIENTS WITH VESICULAR FEVER | 2016 |
|
RU2627652C1 |
| METHOD FOR PREDICTING ACANTHOLYTIC PEMPHIGUS RECURRENCE | 2001 |
|
RU2199127C1 |
| METHOD FOR DETECTING TREATMENT-RESISTANT PATIENTS WITH CHRONIC ADVANCED DERMATOSES (PSORIASIS, ATOPIC DERMATITIS, ACANTHOLYTIC VESICULAR DERMATITIS) | 2011 |
|
RU2457489C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY | 2018 |
|
RU2688212C1 |
| METHOD FOR DETECTION OF STEROID RESISTANCE IN PATIENTS WITH TRUE ACANTOLYTIC PEMPHIGUS ON BASIS OF STUDYING SECONDARY MESSENGER SYSTEM | 2011 |
|
RU2473911C1 |
| METHOD OF TREATING AUTOIMMUNE PEMPHIGUS | 2024 |
|
RU2825823C1 |
